Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Urologic Oncology|June 18, 2023
Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still outJorge Esteban-Villarrubia, Carmen Romero Ferreiro, Lucía Carril-Ajuria, et al.
Clinical Genitourinary Cancer|February 3, 2026
Clinical Outcomes of Targeted Therapies Following HIF-2α Inhibition in Metastatic Renal Cell Carcinoma: A Real-World AnalysisPatricia Rioja, Macarena Rey-Cárdenas, Jorge Esteban-Villarrubia, et al.
Cancers|August 12, 2022
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) OncogeneJavier Torres-Jiménez, Jorge Esteban-Villarrubia, Reyes Ferreiro-Monteagudo
Cancers|December 10, 2021
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical OncologistJavier Torres-Jiménez, Jorge Esteban-Villarrubia, Reyes Ferreiro-Monteagudo, et al.
Cancer Treatment Reviews|July 20, 2024
Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinomaPatricia Rioja, M Rey-Cardenas, Guillermo De Velasco
Cancers|February 11, 2023
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder CancerJorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literatureGuillermo de Velasco, Cesar Munoz, Juan M Sepulveda, et al.
Urologic Oncology|October 21, 2015
Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line settingGuillermo de Velasco, Lana Hamieh, Suzanne Mickey, et al.
Cancer Treatment Reviews|June 1, 2012
Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkersDaniel Castellano, Alain Ravaud, Manuela Schmidinger, et al.
Medicine|November 26, 2019
Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinomaAlberto Carretero-González, Javier Salamanca Santamaría, Daniel Castellano, et al.
Pageof 12